CADTH Canadian Drug Expert Committee, & Canadian Agency for Drugs and Technologies in Health. (2016). CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.): Indication : type 2 diabetes mellitus. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health.
Chicago Style CitationCADTH Canadian Drug Expert Committee, and Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Final Recommendation: Empagliflozin / Metformin Hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.): Indication : Type 2 Diabetes Mellitus. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2016.
MLA CitationCADTH Canadian Drug Expert Committee, and Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Final Recommendation: Empagliflozin / Metformin Hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.): Indication : Type 2 Diabetes Mellitus. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2016.